Cellebrite DI (CLBT) vs Teradata (TDC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Teradata (TDC) has outperformed Cellebrite DI (CLBT) over the past year, gaining 36.6% versus a loss of 40.3%. Over five years, CLBT leads with a +9.4% price change compared with -47.3% for TDC. Cellebrite DI is the larger company by market cap ($2.85 billion vs $2.82 billion), about 1.0 times the size.
On valuation, Teradata trades at a lower forward P/E (10.4x vs 17.4x for Cellebrite DI). Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus 7.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLBT | TDC |
|---|---|---|
| Share price | $11.34 | $30.29 |
| Market cap | $2.85B | $2.82B |
| 1-day change | +1.02% | +3.88% |
| YTD return | -37.10% | -0.49% |
| 1-year return | -40.28% | +36.63% |
| 5-year return | +9.35% | -47.30% |
| P/E ratio (TTM) | 49.30 | 6.36 |
| Forward P/E | 17.36 | 10.40 |
| EPS (TTM) | $0.23 | $4.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $475.68M | $1.66B |
| Revenue growth (YoY) | +18.56% | -4.97% |
| Net income (latest FY) | $78.33M | $130.00M |
| Gross margin | 84.20% | 59.35% |
| Operating margin | 13.98% | 12.33% |
| Net margin | 16.47% | 7.82% |
| 52-week high | $19.98 | $41.78 |
| 52-week low | $9.58 | $20.33 |
| Distance from 52-week high | -43.24% | -27.50% |
| Analyst consensus | none | none |
| Avg. price target upside | +35.45% | +10.60% |
| Average volume | 2.96M | 2.41M |
| Shares outstanding | 251.34M | 93.00M |
| Employees | 1,285 | 5,100 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TDC has outperformed CLBT by 76.9 percentage points over the past year.
- Cellebrite DI trades at a higher earnings multiple (49.3x vs 6.4x trailing P/E).
- Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus 7.8 cents for Teradata.
- Cellebrite DI grew revenue faster in its latest fiscal year (+18.56% vs -4.97%).
About Cellebrite DI
CLBT stock →Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Technology · Computer Software: Prepackaged Software · 1,285 employees
About Teradata
TDC stock →Teradata Corporation, together with its subsidiaries, provides an AI and knowledge platforms in the United States and internationally. It operates in two segments, Product Sales and Consulting Services.
Technology · Computer Software: Prepackaged Software · 5,100 employees
CLBT vs TDC FAQ
Which is bigger, Cellebrite DI or Teradata?
Cellebrite DI (CLBT) is larger, with a market capitalization of $2.85B compared with $2.82B for Teradata (TDC).
Which stock has performed better over the past year, CLBT or TDC?
TDC returned +36.63% over the past 12 months, compared with -40.28% for CLBT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CLBT or TDC?
TDC has the lower trailing P/E at 6.4, versus 49.3 for CLBT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Cellebrite DI and Teradata in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.